State of Reform News

Eli Kirshbaum

|

Expert says HR 3 won’t inhibit pharmaceutical innovation in So-Cal, contradicting claims from PhRMA

A federal bill that would allow Medicare to negotiate prescription drug prices is failing to progress because several congressional representatives from areas with robust pharmaceutical ...

Read More